<![CDATA[Merrimack Pharmaceuticals 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=22281>Sat, 16 May 2026 21:27:44 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Merrimack Pharmaceuticals Announces MM-398 Achieves Primary Endpoint of Overall Survival in Phase 3 Trial in Post-Gemcitabine Metastatic Pancreatic Cancer]]>https://www.newswire.co.kr/newsRead.php?no=748814Thu, 01 May 2014 19:00:00 +0900